Access Bio is a global leader in the development and commercialization of in vitro diagnostics technology. With a mission to improve the lives and well-being of people worldwide, Access Bio has successfully produced high-quality diagnostic products to combat serious diseases such as malaria and HIV. The company is a trusted partner to international public health agencies and organizations, including the World Health Organization and the Bill and Melinda Gates Foundation.
Access Bio offers a comprehensive range of diagnostic tests, including COVID-19 detection kits, rapid diagnostic tests, analyzers, and molecular diagnostics. Their suite of products includes PCR, serology, and antigen testing to meet the need for accurate and reliable screening during the COVID-19 pandemic. With a commitment to innovation and adaptability, Access Bio continues to lead the fight against COVID-19 and other infectious diseases.
Generated from the website
